Bio-Techne Corp. (TECH)
Health Care ยท Biological Products, (No Diagnostic Substances)
Bio-Techne Corp. (TECH) is listed on Nasdaq, where its shares have traded since May 8, 1989. SentiSense covers Bio-Techne Corp. in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances). Kim Kelderman is its chief executive officer. The company reports 3,000 employees, and its corporate website is www.bio-techne.com.
About Bio-Techne Corp.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Latest reported results
Bio-Techne reported revenue of $299.7 million for Q1 FY2027, up 4.6% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 581 institutions reported holding TECH, with 172.2 million shares worth $12.1 billion in aggregate. The largest reported holders were Vanguard, BlackRock and FMR. Of the 5 largest reported holders, 1 opened a new position in TECH and 4 added shares during the quarter.
More on TECH
- TECH sentiment: whether news and social coverage of Bio-Techne Corp. leans bullish or bearish, and the stories driving it.
- TECH ownership: all 581 reporting institutions, plus insider and congressional trades.
- TECH financials: revenue, net income, operating margin and free cash flow through Q1 FY2027.
Frequently asked questions
What does Bio-Techne Corp. do?
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets.
What sector is TECH in?
SentiSense classifies Bio-Techne Corp. in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances).
Where does TECH stock trade?
Bio-Techne Corp. (TECH) is listed on Nasdaq, where its shares have traded since May 8, 1989.
Who is the CEO of Bio-Techne Corp.?
Kim Kelderman is the chief executive officer of Bio-Techne Corp..